Investor Relations > details

Article’s about rhNRG-1’s Animal Model Study was Commented by JACC Editors


In Oct. 3rd, 2006, Zensun published rhNRG-1’s animal model study results in JACC. This article was recognized as hot topic and highlighted by the journal.

Also, Dr. Freedman and Dr. Ginsburgh from Oxford Medical Center published an editorial comments on our results. They think our study provide a remarkable case of such “bedside-to-bench” research and demonstrate that neuregulin-1 therapy substantially mitigates heart failure in infarct-, viral-, anthracycline-, and pacing-induced models that employ rodents and dogs—experimental proofs of concept critical for launching human studies.